Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post -Transplant

Grant

Date/time Interval

  • September 1, 2019 - August 31, 2022
  • Total Award Amount

  • 90000.00
  • Direct Costs

  • 60606.00
  • Sponsor Award Id

  • N006814115
  • Contributor

  • Daniel Feig   Investigator  
  • Michael Seifert   Principal Investigator